Seoul, South Korea

SAng Hyeon Kang

USPTO Granted Patents = 70 

 

Average Co-Inventor Count = 5.8

ph-index = 7

Forward Citations = 117(Granted Patents)


Inventors with similar research interests:


Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
70 patents (USPTO):Explore Patents

Title: Unveiling the Inventive Mind of Sang Hyeon Kang

Introduction:

Sang Hyeon Kang, a prolific inventor based in Seoul, South Korea, has made significant contributions to the field of microbiology with a total of 64 patents under his name. His groundbreaking research on bacteriophages has paved the way for innovative treatments targeting bacterial infections. Let's delve into the remarkable journey of this visionary inventor.

Latest Patents:

Among his latest patents is the bacteriophage Aer-HYP-3, which showcases Kang's expertise in isolating natural Myoviridae bacteriophages with the remarkable ability to combat bacteria effectively. This discovery, represented by SEQ ID NO: 1, not only kills bacteria but also offers a novel method for preventing and treating diseases caused by bacterial infections. Additionally, Kang's research has led to the development of compositions and methods for inhibiting the proliferation of pathogenic bacteria, such as the Podoviridae bacteriophage Esc-COP-30.

Career Highlights:

Sang Hyeon Kang has left an indelible mark on the biotechnology industry through his work with esteemed companies such as Intron Biotechnology, Inc., and Samsung Electronics Co., Ltd. His innovative approach to microbiology and relentless pursuit of advancements in phage therapy have garnered widespread recognition within the scientific community.

Collaborations:

Throughout his career, Kang has collaborated with talented individuals in the field, including notable coworkers like Seong Jun Yoon and Soo Youn Jun. These collaborations have not only enriched his research endeavors but have also fostered a culture of innovation and knowledge-sharing within the organizations he has been a part of.

Conclusion:

In conclusion, Sang Hyeon Kang stands as a beacon of innovation in the realm of microbiology, with a portfolio of patents that reflect his dedication to pushing the boundaries of scientific discovery. His pioneering work in bacteriophage research continues to inspire new avenues for combating bacterial infections, offering hope for improved treatment modalities. Kang's legacy as an inventor is testament to the transformative power of human ingenuity in the face of complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…